ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,033.11
0.94%
US Tech 100
21,254.00
-0.55%
Dow Jones
42,515.09
0.00%
Brent Oil
73.935
3.03%
Bitcoin
105,668.45
-1.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Praxis Precision Medicines Inc (PRAX) Quote

Praxis Precision Medicines Inc

Praxis Precision Medicines Inc (PRAX)

NASDAQ
43.81
-0.49
(-1.11%)
Closed June 16 4:00PM
15 min delayed - Upgrade to Realtime
43.81
0.00
( 0.00% )
Pre Market: 7:32AM
15 min delayed - Upgrade to Realtime

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
43.81
Bid
32.03
Ask
70.09
Volume
-
0.00 Day's Range 0.00
26.70 52 Week Range 91.83
Market Cap
892.365M
Previous Close
43.81
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
416,310
Shares Outstanding
20,368,982
Dividend Yield
-
PE Ratio
-4.88
Earnings Per Share (EPS)
-8.98
Revenue
8.55M
Net Profit
-182.82M

About Praxis Precision Medicines Inc

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.praxismedicines.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Praxis Precision Medicines Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRAX. The last closing price for Praxis Precision Medicines was $43.81. Over the last year, Praxis Precision Medicines shares have traded in a share price range of $ 26.70 to $ 91.83.

Praxis Precision Medicines currently has 20,368,982 shares outstanding. The market capitalization of Praxis Precision Medicines is $892.37 million. Praxis Precision Medicines has a price to earnings ratio (PE ratio) of -4.88.

Ask ADVFN Intelligence (AI)

PRAX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
May 02 2025
PRAX (-1.11%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 02 2025
PRAX (-1.11%)

Form 8-K - Current report
Edgar (US Regulatory)
May 02 2025
PRAX (-1.11%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 30 2025
PRAX (-1.11%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
March 19 2025
PRAX (-1.11%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 28 2025
PRAX (-1.11%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 28 2025
PRAX (-1.11%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
February 28 2025
PRAX (-1.11%)

Form 8-K - Current report
Edgar (US Regulatory)
February 28 2025
PRAX (-1.11%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.68-1.5284333558144.4946.9343.0322519044.88224221CS
46.6617.927321668937.1546.9335.2129607041.34393071CS
126.4717.327262988837.3446.9326.741631036.45018758CS
26-27.93-38.932255366671.7491.8326.744318049.82062656CS
524.5811.674738720439.2391.8326.737411954.31535556CS
15614.5649.777777777829.2591.8311.8572807333.43695377CS
260-364.34-89.2662011515408.15914.257511.8561922881.44340428CS

PRAX - Frequently Asked Questions (FAQ)

What is the current Praxis Precision Medicines share price?
The current share price of Praxis Precision Medicines is $ 43.81
How many Praxis Precision Medicines shares are in issue?
Praxis Precision Medicines has 20,368,982 shares in issue
What is the market cap of Praxis Precision Medicines?
The market capitalisation of Praxis Precision Medicines is USD 892.37M
What is the 1 year trading range for Praxis Precision Medicines share price?
Praxis Precision Medicines has traded in the range of $ 26.70 to $ 91.83 during the past year
What is the PE ratio of Praxis Precision Medicines?
The price to earnings ratio of Praxis Precision Medicines is -4.88
What is the cash to sales ratio of Praxis Precision Medicines?
The cash to sales ratio of Praxis Precision Medicines is 104.33
What is the reporting currency for Praxis Precision Medicines?
Praxis Precision Medicines reports financial results in USD
What is the latest annual turnover for Praxis Precision Medicines?
The latest annual turnover of Praxis Precision Medicines is USD 8.55M
What is the latest annual profit for Praxis Precision Medicines?
The latest annual profit of Praxis Precision Medicines is USD -182.82M
What is the registered address of Praxis Precision Medicines?
The registered address for Praxis Precision Medicines is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Praxis Precision Medicines website address?
The website address for Praxis Precision Medicines is www.praxismedicines.com
Which industry sector does Praxis Precision Medicines operate in?
Praxis Precision Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ACXPAcurx Pharmaceuticals Inc
$ 0.90
(193.06%)
38.94M
SLRXSalarius Pharmaceuticals Inc
$ 1.18
(88.77%)
21.74M
CEROCERo Therapeutics Holdings Inc
$ 12.04
(75.31%)
3.56M
VERVVerve Therapeutics Inc
$ 10.97
(74.96%)
3.75M
SAFXXCF Global Inc
$ 3.65
(65.16%)
10.74M
RUNSunrun Inc
$ 6.46
(-32.99%)
1.44M
SEDGSolarEdge Technologies Inc
$ 17.50
(-27.02%)
405k
ADILAdial Pharmaceuticals Inc
$ 0.2398
(-26.24%)
569.73k
CDTGCDT Environmental Technology Investment Holdings Ltd
$ 1.05
(-23.44%)
96.06k
DYNDyne Therapeutics Inc
$ 10.70
(-22.58%)
48.49k
GTIGraphjet Technology
$ 0.0819
(6.92%)
72.31M
ACXPAcurx Pharmaceuticals Inc
$ 0.90
(193.06%)
38.94M
TDTHTrident Digital Tech Holdings Ltd
$ 0.273
(11.66%)
32.73M
GNLNGreenlane Holdings Inc
$ 0.0122
(-1.61%)
30.15M
SLRXSalarius Pharmaceuticals Inc
$ 1.18
(88.77%)
21.74M

PRAX Discussion

View Posts
Monksdream Monksdream 9 months ago
PRAX near a 52/week high

👍️0
Monksdream Monksdream 2 years ago
PRAX under $2
👍️0
richme richme 2 years ago
Do you still have your 10K shares?

Hope this one goes up to new heights in $5+ in the next month or so.
👍️0
makinezmoney makinezmoney 2 years ago
$PRAX: Added 10k here now at 1.22


Technically........ bullish ...... should get to $1.80 min



GO $PRAX
👍️0
ctb ctb 2 years ago
Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
Vandana Singh
Fri, March 3, 2023 at 8:05 AM PST

https://finance.yahoo.com/news/despite-trial-failure-praxis-still-160535252.html
👍️0
IPO$ IPO$ 2 years ago
News today.
👍️0
IPO$ IPO$ 2 years ago
Not looking good now.
👍️0
IPO$ IPO$ 2 years ago
Getting killed this am.
👍️0
IPO$ IPO$ 2 years ago
FDA phase 2 approval due in next week or so.
👍️0
IPO$ IPO$ 2 years ago
ATM offering on S-3 didn’t hurt 2022 as avg price was $3.90 per share but not sure on 2023.
👍️0
IPO$ IPO$ 2 years ago
Book value at 12/31/22 is $76M. Not bad. They say they have enough cash entering 2023.
👍️0
IPO$ IPO$ 2 years ago
$61M cash at 12/31/22 with 49M shares O/S for about $1.30 in cash per share.
👍️0
IPO$ IPO$ 2 years ago
I wonder how much cash they have now?
👍️0
ElCollector ElCollector 3 years ago
$PRAX has $5 a share cash and easily going from $2 to $3 for my collection....patiently waiting
👍️0
rtrstock rtrstock 4 years ago
Looking for a gain.
👍️0

Your Recent History

NASDAQ
PRAX
Praxis Precision Medicines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads